Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: EMERGENT BIOSOLUTIONS CANADA INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2019-05-31 to 2025-06-13
Current total value of award: $316667654
Description: VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATED SERVICES FOR UP TO 10 YEARS.